A phase-Ib study of TRK-950 combined with anticancer treatment regimens in patients with gastric and gastro-esophageal junction (GEJ) cancer. Article

Web of Science: 001093994600431

Cited authors

  • Cassier PA, Matrana MR, Hanna DL, George B, Sharma S, Kelly RJ, Okano F, Von Hoff DD, Blay JY

Publication date

  • 2023

Published in

International Standard Serial Number (ISSN)

  • 0732-183X

Number of pages

  • 1

Start page

  • 361

End page

  • 361


  • 41